Levodopa and Growth Hormone Secretion SIR,-In your leading article on "Glucagon and Growth Hormone" (27 January, p. 188) you state that glucagon stimulation is an effective test of growth hormone release but, since it is less reliable and takes longer to perform than the insulin test, it should be regarded only as "a good second-line test." T hough Drs. C. T. Sawin and M. L. Mitchell (1 September, p. 499) have pointed out that the reliability of the glucagon provocative test can be improved by pretreatment with propranolol,l we should like to draw attention to another reliable test of growth hormione release, using levodopa as the stimulant, which has recently been investigated by several authors, including ourselves.2-4 The preliminary results of our study of the effect of levodopa on growth hormone release in elderly normal subjects and in elderly subiects with cerebrovascular hemiplegia are reported briefly here.
Plasma growth hormone levels before and after a single oral dose of levodopa (500 mg) were measured by a double antibody rad'oimmunoassay technique in seven clinically normal elderly subjects aged 64-83 (average 77-0) years and in seven elderlv patients aged 66-76 (average 72.4) years with arterosclerotic hemiplegia of at least three months' duration. Mild side effects of levodopa (nausea) were noted in only four of the 14 subjects. Significant peak levels of growth hormone were found, usually between 60 and 90 minutes after levodopa administration, in 11 of the 14 subjects investigated. Th2re was no significant difference in response between the hemniplegic patients (mean peak plasma growth hormone level (± S.D.) 21-7 ± 6-41 ng/ml) and the control group (26-14 ± 5-43 ng/ml). Nor was any significant difference noted between the responses of these two groups of subjects and those of nomial adults previously studied.4
These results confirm that levodopa stimulation should be regarded as a reliable test of growth hormone release in patients of all ages. Moreover, the test is short in duration, does not require any intravenous infusion or injection, and does not involve any risk of hypoglycaemia. The mean values for serum TSH, cholesterol, and triglyceride levels in August were not significantly different from those in January (see table) 
False Interpretation of Fetal Heart
Monitoring SIR,-Mr. I. L. Craft and his colleagues (29 September, p. 694) have drawn attention to a case in which the maternal rather than the fetal heart *rate was recorded by a HewlettPackard fetal heart monitor during labour.
The case they describe is one in which, when the fetus was known to have died some time before, a record was obtained on the monitor whiich proved to be maternal in origin though indistinguishable from a normal fetal heart rate. The explanation for this phenomenon is that once the fetus dies the fetus acts as a conductor for the lower voltage maternal E.C.G. signal which is not cancelled out by the fetal signal. A similar case, with a slower maternal heart rate, has been reported previously.' As the authors point out, it is important to be aware that this can hapDen-on one occasion an unnecessary caesarean section was performed when the fetus had been dead for several hours (personal communication). However, caution must be exercised before making the assumption that the maternal heart rate can
